Is TB-500 Legal in Tennessee? How to Access It Legally
HealthRX.com
No federal approval makes TB-500 clearly legal to obtain
See the public record for TB-500
At a glance
- What it is / a synthetic seven-amino-acid fragment of thymosin beta-4, not the full protein [1]
- FDA approval / none; no approved product in the countries FDA checked, including Canada and the UK [1]
- Compounding lists / absent from FDA's pharmacy and outsourcing-facility bulks lists and all three interim categories [5][6][2]
- Advisory vote / July 23, 2026 vote favored listing TB-500; advice only [7][3]
- HHS draft policy / enforcement discretion for TB-500 acetate injections [3][4]
- Human data / FDA found no article in which TB-500 was given to a person [1]
- Sport / prohibited at all times by WADA [8]
Is TB-500 approved or listed for compounding?
Not approved. FDA's July 2026 review found no USP or National Formulary monograph, no FDA-approved drug containing TB-500, and no approved product in Canada, Australia, the UK, the EU countries it checked, or authorized by the European Medicines Agency [1]. TB-500 is a synthetic, N-acetylated seven-amino-acid fragment (residues 17 to 23) of the 43-amino-acid protein thymosin beta-4, not the full protein [1].
A state-licensed pharmacy may compound with a bulk substance only if it complies with a USP or NF monograph where one exists, is a component of an FDA-approved drug, or appears on FDA's list of bulk substances that compounders may use [2]. TB-500 meets none of the three, and it sits in none of the three interim categories on FDA's lists for pharmacies and physicians or for outsourcing facilities [1][5][6][2]. It appears in the 'nominated but withdrawn' table of FDA's page on bulk substances that may present significant safety risks, which holds substances previously in that risk category whose nominators withdrew them [9]. Removal from that category was not a finding that TB-500 is safe. FDA's stated concerns include that it has not identified any human exposure data and that injectable peptides may pose immunogenicity risk from aggregation and peptide-related impurities [9].
What the 2026 advisory vote and HHS draft policy change
FDA's Pharmacy Compounding Advisory Committee voted on July 23, 2026 in favor of adding TB-500 to the bulks list, against FDA staff's recommendation [1][7][3]. The vote is advice only: TB-500 is not on the list, and adding it takes formal rulemaking [7][3].
HHS's draft enforcement-discretion policy, filed October 28, 2026, names TB-500 among six peptides and covers TB-500 acetate given by subcutaneous or intramuscular injection [3][4]. HHS says it does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding with it when conditions are met, such as a single active ingredient, a patient-specific prescription, and a FDA-registered manufacturer with a certificate of analysis [3][4]. The notice states that it does not establish any rights for any person and is not binding on HHS or the public [3].
What this means for access in Tennessee
Federal rules restrict when a pharmacy may compound TB-500 from a bulk substance [2]. FDA found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1]. State-level pharmacy and prescribing rules in Tennessee are not covered on this page.
Online sellers ship research-use-only injectable powder in 2 mg to 15 mg vials [1]. FDA found no human exposure data on TB-500, no nonclinical toxicity studies and no immunogenicity data, so safety in humans is unknown; its adverse-event search through March 26, 2025 returned no TB-500 reports [1].
WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3 and prohibits it at all times, in and out of competition [8][10].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
Questions worth asking
Frequently asked questions
Is TB-500 legal in Tennessee?
Can a Tennessee doctor prescribe TB-500 and have it filled?
Does the advisory committee vote make TB-500 legal?
Is TB-500 the same as thymosin beta-4?
References
Show all 10 referencesHide references
- U.S. Food and Drug Administration.
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act | FDA.
- Official web page.
- Official web page.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- World Anti-Doping Agency.